Phibro Animal Health | PAHC - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Align Technology USD 821.72M 43.15M 2026-09
ANI Pharmaceuticals USD 637.11M 39.9M 2026-09
Aurora Cannabis CAD 76.28M 28.24M 2026-06
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Canopy Growth CAD 98.74M 23K 2026-06
Corcept Therapeutics USD 225.75M 10.9M 2026-09
Eli Lilly USD 10.52B 496M 2026-06
Henry Schein USD 3.27B 8M 2026-09
Idexx Laboratories USD 811.89M 20.87M 2026-09
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Merck USD 10.75B 5.02B 2026-09
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Pacira USD 1.18B 995.96M 2026-09
Phibro Animal Health USD 417.67M 1.04B 2026-09
Prestige Brands USD 213.19M 7.06M 2026-06
Supernus Pharmaceuticals USD 1.06B 31.25M 2026-09
Zoetis USD 3.3B 155M 2026-09